Skip to content

Study on Clinical Efficacy of Flavored Xanthium Powder in Treating Allergic Rhinitis

Study on the mechanism and material basis of xanthium about relieving stuffy nose to treat allergic rhinitis based on network target and UPLC-Q-Orbitrap HRMS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042833
Enrollment
Unknown
Registered
2021-01-30
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Modern medical diagnostic criteria of allergic rhinitis; 2. Comply with TCM "Rhinitis" disease diagnosis and TCM diagnostic criteria for lung-qi deficiency and cold syndrome; 3. The gender and age of the patient are not limited; 4. The patient's communication skills are normal and have good compliance with observation and evaluation; 5. Volunteer to participate in the research and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or breastfeeding, have asthma, immunodeficiency diseases, tumors and other heart, liver, kidney, and mental diseases; 2. Those who have taken corticosteroids, antihistamines, and Chinese medicine within 2 weeks; 3. Those who are known to be allergic to the test drug or a certain Chinese medicine in the test drug; 4. Patients with respiratory infections; 5. Patients who have participated in other clinical studies in the past six months.

Design outcomes

Primary

MeasureTime frame
Serum specific IgE detection;Nasal secretion eosinophil count;

Countries

China

Contacts

Public ContactZhang Hai
zhanghai@cdutcm.edu.cn+86 28-61800104

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026